Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-12 12:29 pm Purchase | 2024-12-06 | 13G | PMV Pharmaceuticals, Inc. PMVP | BML Investment Partners, L.P. | 3,269,907 6.300% | 3,269,907 (New Position) | Filing History |
| 2024-11-14 12:24 pm Purchase | 2024-09-30 | 13G | PMV Pharmaceuticals, Inc. PMVP | ArrowMark Colorado Holdings LLC | 3,647,291 7.080% | 933,148 (+34.38%) | Filing History |
| 2024-07-08 4:32 pm Sale | 2024-06-30 | 13G | PMV Pharmaceuticals, Inc. PMVP | BlackRock Inc. BLK | 1,162,193 2.300% | -2,067,604 (-64.02%) | Filing History |
| 2024-04-09 1:17 pm Sale | 2024-03-29 | 13G | PMV Pharmaceuticals, Inc. PMVP | JPMORGAN CHASE & CO JPM | 15,573 0.000% | -3,659,241 (-99.58%) | Filing History |
| 2024-02-14 4:58 pm Sale | 2023-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | CITADEL ADVISORS LLC | 1,236,850 2.400% | -1,022,891 (-45.27%) | Filing History |
| 2024-02-14 4:02 pm Sale | 2023-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | Boxer Capital LLC | 0 0.000% | -3,163,795 (Position Closed) | Filing History |
| 2024-02-14 3:38 pm Purchase | 2023-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | ArrowMark Colorado Holdings LLC | 2,714,143 5.310% | 2,714,143 (New Position) | Filing History |
| 2024-02-14 09:18 am Sale | 2023-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | AVORO CAPITAL ADVISORS LLC | 0 0.000% | -3,060,000 (Position Closed) | Filing History |
| 2024-02-14 07:52 am Sale | 2023-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | RTW Investments, LP | 0 0.000% | -4,356,920 (Position Closed) | Filing History |
| 2024-02-13 5:12 pm Sale | 2023-12-29 | 13G | PMV Pharmaceuticals, Inc. PMVP | The Vanguard Group | 2,405,307 4.700% | -348,299 (-12.65%) | Filing History |
| 2024-01-29 3:26 pm Sale | 2023-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | BlackRock Inc. BLK | 3,229,797 6.300% | -1,447,231 (-30.94%) | Filing History |
| 2024-01-23 09:40 am Sale | 2023-12-29 | 13G | PMV Pharmaceuticals, Inc. PMVP | JPMORGAN CHASE & CO JPM | 3,674,814 7.100% | -329,953 (-8.24%) | Filing History |
| 2024-01-23 09:07 am Purchase | 2023-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | STATE STREET CORP STT | 723,454 1.410% | 76,904 (+11.89%) | Filing History |
| 2023-08-23 4:56 pm Sale | 2023-08-09 | 13D | PMV Pharmaceuticals, Inc. PMVP | ORBIMED ADVISORS LLC | 6,563,077 13.500% | -26,253 (-0.40%) | Filing History |
| 2023-07-07 4:35 pm Purchase | 2023-06-30 | 13G | PMV Pharmaceuticals, Inc. PMVP | BlackRock Inc. BLK | 4,677,028 10.200% | 1,225,661 (+35.51%) | Filing History |
| 2023-05-19 4:05 pm Purchase | 2023-05-09 | 13G | PMV Pharmaceuticals, Inc. PMVP | CITADEL ADVISORS LLC | 2,259,741 4.900% | 875,242 (+63.22%) | Filing History |
| 2023-05-10 09:19 am Sale | 2023-04-30 | 13G | PMV Pharmaceuticals, Inc. PMVP | STATE STREET CORP STT | 646,550 1.410% | -2,660,686 (-80.45%) | Filing History |
| 2023-02-14 1:10 pm Purchase | 2022-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | Boxer Capital LLC | 3,163,795 6.900% | 325,559 (+11.47%) | Filing History |
| 2023-02-14 10:07 am Purchase | 2022-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | RTW Investments, LP | 4,356,920 9.500% | 1,375,960 (+46.16%) | Filing History |
| 2023-02-14 09:35 am Purchase | 2022-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | AVORO CAPITAL ADVISORS LLC | 3,060,000 6.700% | 1,595,000 (+108.87%) | Filing History |